LIACX
Price
$11.23
Change
-$0.49 (-4.18%)
Updated
Feb 21 closing price
Net Assets
2.56B
PMAQX
Price
$45.48
Change
-$0.77 (-1.66%)
Updated
Feb 21 closing price
Net Assets
29.57B
Ad is loading...

LIACX vs PMAQX

Header iconLIACX vs PMAQX Comparison
Open Charts LIACX vs PMAQXBanner chart's image
Columbia Acorn C
Price$11.23
Change-$0.49 (-4.18%)
VolumeN/A
Net Assets2.56B
Principal MidCap R6
Price$45.48
Change-$0.77 (-1.66%)
VolumeN/A
Net Assets29.57B
LIACX vs PMAQX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LIACX vs. PMAQX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LIACX is a Hold and PMAQX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 29.6B vs. LIACX (2.56B). PMAQX pays higher dividends than LIACX: PMAQX (0.10) vs LIACX (0.00). LIACX was incepted earlier than PMAQX: LIACX (24 years) vs PMAQX (8 years). LIACX is a more actively managed with annual turnover of: 64.00 vs. PMAQX (10.10). PMAQX has a lower initial minimum investment than LIACX: PMAQX (0) vs LIACX (2000). PMAQX annual gain was more profitable for investors over the last year : 12.83 vs. LIACX (3.98). PMAQX return over 5 years is better than : 37.29 vs. LIACX (-34.01).
LIACXPMAQXLIACX / PMAQX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years8 years-
Gain YTD-4.5881.905-241%
Front LoadN/AN/A-
Min. Initial Investment20000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.56B29.6B9%
Annual Yield % from dividends0.000.10-
Returns for 1 year3.9812.8331%
Returns for 3 years1.5429.105%
Returns for 5 years-34.0137.29-91%
Returns for 10 years-89.43N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AZEMX11.35-0.04
-0.35%
Alger Emerging Markets Z
NYVCX21.24-0.32
-1.48%
Davis NY Venture C
RSPFX27.98-0.50
-1.76%
Victory RS Partners A
VYSDX10.71-0.29
-2.64%
Voya Small Company R
LMORX39.15-1.16
-2.88%
Patient Opportunity R